Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C430
http://purl.obolibrary.org/obo/NCIT_C430
|
|---|---|
| Preferred Name | Zalcitabine |
| Definitions |
A synthetic dideoxynucleoside. After intracellular phosphorylation to its active metabolite, zalcitabine preferentially inhibits the gamma form of DNA polymerase present in tumor cell mitochondria, resulting in the inhibition of tumor cell mitochondrial DNA replication and tumor cell death. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A synthetic dideoxynucleoside. After intracellular phosphorylation to its active metabolite, zalcitabine preferentially inhibits the gamma form of DNA polymerase present in tumor cell mitochondria, resulting in the inhibition of tumor cell mitochondrial DNA replication and tumor cell death. (NCI04) |
|---|---|
| prefLabel | Zalcitabine
|
| label | Zalcitabine
|
| CHEBI_ID | CHEBI:10101
|
| PDQ_Closed_Trial_Search_ID | 40349
|
| code | C430
|
| prefixIRI | NCIT:C430
|
| in_subset | |
| Preferred_Name | Zalcitabine
|
| FDA_UNII_Code | 6L3XT8CB3I
|
| Contributing_Source | FDA
|
| Chemical_Formula | C9H13N3O3
|
| Maps_To | Zalcitabine
|
| CAS_Registry | 7481-89-2
|
| NSC Number | 606170
|
| NCI_Drug_Dictionary_ID | 40349
|
| Legacy Concept Name | Zalcitabine
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 40349
|
| Semantic_Type |
Pharmacologic Substance
Nucleic Acid, Nucleoside, or Nucleotide
|
| UMLS_CUI | C0012132
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |